Skip directly to search Skip directly to A to Z list Skip directly to site content

Lead Toxicity
What Tests Can Assist with Diagnosis of Lead Toxicity?

Course: WB 1105
CE Original Date: August 20, 2007
CE Renewal Date: August 20, 2010
CE Expiration Date: August 20, 2012
en Español
Download Printer-Friendly version [PDF - 1.34 MB]

Previous Section Next Section

Learning Objectives

Upon completion of this section, you will be able to

  • name the most useful test for lead toxicity

Introduction

Venous Blood Lead Level (BLL) testing is the most useful screening and diagnostic test for recent or ongoing lead exposure as opposed to past exposures.

Blood Lead Levels

Different tests have been used in the past to evaluate lead exposure and/or to gauge the effects of lead exposure.

  • Venous BLL testing is the most useful screening and diagnostic test for recent or ongoing lead exposure as opposed to past exposures.
  • Given the greater risk of contamination using the finger-stick method, an elevated BLL obtained through finger-sticking should always be confirmed through venipuncture. (AAP 1993 and CDC, 1997a)
  • BLLs respond relatively rapidly to abrupt or intermittent changes in lead intake (for example, ingestion of lead paint chips by children) and, for relatively short exposure periods, bear a linear relationship to those intake levels.
  • For individuals with high or chronic past exposure, however, BLLs often under-represent the total body burden because most lead is stored in the bone and may have “normal” levels in the blood.
  • One exception is patients with a high body burden under physiological stressful circumstances whose BLLs may be elevated from the release of lead stored in bones.
  • Erythrocyte protoporphyrin (EP), commonly assayed as zinc protoporphyrin (ZPP), was previously considered the best test for screening for asymptomatic children, however, is not sufficiently sensitive at lower BLLs and therefore is not as useful a screening test for lead exposure as previously thought.

Over the past 30 years, there has been a dramatic decline, nationwide, in blood lead levels (BLLs). Findings from the most recent National Health and Nutrition Examination Survey (NHANES), 1999 – 2002, indicate that BLLs are continuing to decrease across all age and racial/ethnic groups in the U.S. Although BLLs remained higher for young non-Hispanic black children, this group also experienced the greatest decline (72%) in elevated BLLs since1991-1994. (CDC 2005)

  • The overall prevalence of elevated BLLs (≥ 10 µg/dL) for the U.S. population was 0.7%. (CDC 2005)
  • The average BLL for children 1-5 years of age was 1.9 µg/dL in 2002, down from 15.0 µg/dL in 1976-1980 (before leaded gasoline was banned; CDC 2005).
  • The average BLL for adults 18-74 years of age was 14.2 µg/dL from 1976-70; in 1988-1991, the average BLL for adults was 3.0 µg/dL (CDC 1997b).
  • An attempt should be made to identify and minimize lead exposures when BLLs indicate that they are occurring at any blood lead level above background population levels.
  • If an adult has a BLL of 20 µg/dL, e.g., an unusual exposure is likely occurring and should be interrupted, if possible. This is especially important for fertile and pregnant females.

EP and ZPP Levels

Recent data indicate that the EP/ZPP assay at lower BLLs is not sufficiently sensitivity, and therefore is not as useful a screening test for lead exposure as previously thought. EP/ZPP assays continue to be used at times as a complement to venous BLL testing and are required by OSHA for some workplace testing.

Normal values of ZPP are usually below 35 µg/dL.

EP is also elevated in

  • iron deficiency anemia
  • jaundice
  • sickle cell
  • other hemolytic anemias

In erythropoietic protoporphyria, an extremely rare disease, EP is markedly elevated (usually above 300 µg/dL).

Other Evaluation Methods

There are different evaluation methods used to study patients with elevated BLL.

  • Complete blood count (CBC) may be useful for patients with extensive exposure. In lead-exposed patients, the hemocrit and hemoglobin values may be slightly to moderately low in the CBC, and the peripheral smear may be either normochromic and normocytic or hypochromic and microcytic.
    • There may be basophilic stippling in patients who have been significantly poisoned for a prolonged period.
    • However, because these results are not specific to lead exposure, the CBC test is not as valuable for detecting lead exposure as the BLL and EP assays.
    • A hypochromic, microcytic anemia should be appropriately differentiated from other causes, especially iron-deficiency anemia by the use of testing for iron, iron binding capacity, and ferritin.
  • Abdominal radiographs may show the presence of radiodense lead foreign bodies in the gastrointestinal tract. These are helpful only in cases of acute ingestion (e.g. of lead sinkers, curtain weights, jewelry, or paint chips) or unusual persistence of high blood lead values. Longbone radiographs can show “lead lines”. These are lines of increased density on the metaphysis growth plate of the bone, showing radiological growth retardation. This is not a routine procedure to identify lead poisoning, but a radiological finding of chronic exposure. See Figure 2 and Figure 3.
  • Because hair and fingernails are subject to external environmental contamination, assaying their lead content is an uncertain estimate of body burden and is not recommended (AAP 1993; CDC 2002).
  • Longbone radiographs are not recommended for diagnosing lead exposure (CDC 2002), however, they are useful to determine reduced growth retardation.
  • Second tier tests (such as neurobehavioral/psychological evaluation for children with indicative findings on exam) should be considered, as appropriate.
  • Evaluation may also appropriately include tests for the health effects of lead.


Figure 2. Longbone Radiograph of Hands - “lead lines” shown as increased density on the metaphysis growth plate of the proximal segments of phalanges and distal segments of ulna and radius in a five-year-old male with radiological growth retardation and blood lead level of 37.7µg/dL. (Photo courtesy of Dr. Celsa López, Clinical Epidemiologic Research Unit, IMSS, Torreón, México)


Figure 3. Longbone Radiograph of knees - “lead lines” in three-year-two-month-old girl with blood lead level of 10.6 µg/dL. Notice the increased density on the metaphysis growth plate of the knee, especially in the femur. (Photo courtesy of Dr. Celsa López, Clinical Epidemiologic Research Unit, IMSS, Torreón, México)

Key Points

  • The best screening and diagnostic tool for evaluating lead exposure is the venous BLL test.
  • Using an EP or ZPP assay to screen children for lead exposure is not as useful as once thought, and not recommended.
  • Other tests may be appropriate for specific situations, such as abdominal radiographs to detect swallowed objects.
  • Secondary testing for other health effects may also be useful.

   

Progress Check

11. What test is best to confirm lead poisoning in a child?

A. EP/ZPP
B. capillary blood lead level (fingerstick)
C. venous blood lead level (BLL)
D. abdominal radiograph

Answer:

To review relevant content, see Blood Lead Levels in this section.

Previous Section Next Section
 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Agency for Toxic Substances and Disease Registry, 4770 Buford Hwy NE, Atlanta, GA 30341
Contact CDC: 800-232-4636 / TTY: 888-232-6348

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #